Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008

Table 1 The prevalence of dispensed drugs, polypharmacy, and excessive polypharmacy

Age group	DP≥1				DP≥5				DP≥10
	2005	2006	2007	2008	2005	2006	2007	2008	2005	2006	2007	2008
0-9	0.183	0.194	0.184	0.188	0.005	0.005	0.005	0.005	0.000	0.000	0.000	0.000
10-19	0.214	0.223	0.228	0.238	0.008	0.008	0.008	0.008	0.000	0.000	0.000	0.001
20-29	0.314	0.313	0.308	0.304	0.016	0.017	0.017	0.017	0.001	0.001	0.001	0.001
30-39	0.332	0.337	0.335	0.333	0.029	0.029	0.029	0.030	0.003	0.003	0.003	0.004
40-49	0.390	0.396	0.395	0.394	0.053	0.054	0.055	0.056	0.008	0.008	0.009	0.009
50-59	0.533	0.536	0.537	0.536	0.113	0.115	0.117	0.119	0.019	0.020	0.020	0.021
60-69	0.640	0.649	0.657	0.662	0.197	0.202	0.209	0.214	0.037	0.039	0.040	0.041
70-79	0.784	0.789	0.794	0.797	0.350	0.359	0.367	0.376	0.078	0.083	0.085	0.088
80-89	0.833	0.843	0.849	0.853	0.475	0.492	0.504	0.514	0.121	0.139	0.143	0.147
90-	0.780	0.790	0.790	0.795	0.494	0.524	0.524	0.532	0.126	0.159	0.160	0.162
Total	0.426	0.433	0.433	0.436	0.102	0.105	0.108	0.111	0.021	0.022	0.023	0.024

The prevalence of dispensed drugs (DP≥1), polypharmacy (DP≥5), and excessive polypharmacy (DP≥10) in different age groups in Sweden 2005-2008. n = 9,029,750 (2005), 9,080,505 (2006) 9,148,092 (2007) and 9,219,637 (2008).